Across TCGA pan-cancer cohorts, UQCC1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated UQCC1 data layer compared with 24 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher UQCC1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated UQCC1 expression acts as an unfavorable survival marker, although some lineages such as COAD and LSCC show a favorable association.
COAD, LSCC, and GBM are the cancer types where UQCC1 mass-spec protein most reproducibly stratifies survival.